Financial highlights

History of revenue growth $ in billions
Net earnings
$ per diluted share
Adjusted net earnings1,2
$ per diluted share
Dividends paid
$ per share of common stock
Financial overview (in millions, except per share amounts)
2016 2015 % Change
Net sales $ 11,325 $ 9,946 13.9
Earnings before income taxes 1,921 1,735 10.7
Income taxes 247 296 (7.4)
Net earnings 1,647 1,439 14.5
Adjusted net earnings2, 3 2,194 1,949 12.6
Net earnings per diluted share of common stock
Reported $ 4.35 $ 3.78 15.1
Adjusted1, 2 5.80 5.12 13.3
Dividends paid per share of common stock $ 1.52 $ 1.38 10.1
Cash, cash equivalents and marketable securities 3,384 4,079 (17.0)
  1. A non-GAAP financial measure. The most comparable GAAP financial measure is net earnings per diluted share.
  2. Click for a reconciliation with GAAP.
  3. A non-GAAP financial measure. The most comparable GAAP financial measure is net earnings.
Reconciliation of non-GAAP financial measures with the most directly comparable GAAP financial measures
Net earnings ($ millions) Net earnings per diluted share
  2011 2012 2013 2014 2015 2016   2011 2012 2013 2014 2015 2016
 
Reported $1,345 $1,298 $1,006 $515 $1,439 $1,647   $3.45 $3.39 $2.63 $1.34 $3.78 $4.35
Acquisition and integration related charges 142 37 72 65 24 100   0.37 0.09 0.19 0.17 0.06 0.26
Amortization of intangible assets 88 98 133 147 221   0.23 0.26 0.35 0.39 0.59
Restructuring-related charges 60 59 46 78 97 98   0.16 0.15 0.12 0.20 0.26 0.26
Recall matters 133 460 628 210 127   0.35 1.20 1.65 0.55 0.34
Regulatory and legal matters 33 63 (46) (7)   0.09 0.17 (0.12) (0.02)
Donations 15   0.04
Tax matters (99) (46) 391 78 8   (0.26) (0.12) 1.02 0.20 0.02
Adjusted $1,448 $1,648 $1,714 $1,810 $1,949 $2,194   $3.72 $4.30 $4.49 $4.73 $5.12 $5.80
  1. Refer to Appendix E to our 2017 proxy statement, available at www.proxymaterials.stryker.com, for additional information regarding our non-GAAP financial measures.

Leading in medtech

MedSurg 43%

14% Instruments

14% Medical

13% Endoscopy

2% Sustainability Solutions

Orthopaedics 39%

13% Knees

12% Trauma & Extremities

11% Hips

3% Other recon

Neurotechnology & Spine 18%

7% Spine

5% Neurovascolar

4% Neuro Powered Instruments

2% Craniomaxillofacial

Global recognition

Best Workplaces For Giving Back

#20 in 2017
out of 50 companies

Best Workplaces in Manufacturing & Production

#4 in 2016
out of 15 companies

Best Workplaces — Spain and Canada

#9 for Spain in 2016
first time participating
#25 for Canada in 2016
recipient for the seventh consecutive year

Best Workplaces For Parents

#24 in 2016
out of 50 companies,
first time on the list

Best Places to Work in Australia

#2 in 2016
recipient for the third consecutive year

The Sunday Times 100 Best Companies to Work For

#19 in 2017
Stryker U.K. recipient for the 11th consecutive year

FORTUNE World’s Most Admired Companies

#5 in 2017
Medical Products & Equipment
award recipient for the 16th consecutive year

FORTUNE 500 Largest U.S.-Based Companies

#287 in 2016
joined the list in 2003 as #493
14th consecutive year on the list

FORTUNE 100 Best Companies to Work For (U.S.)

#19 in 2017
recipient for the seventh consecutive year

Learn more about our business groups: